As of 2026-04-13, the Relative Valuation of Amneal Pharmaceuticals Inc (AMRX) is 6.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.54 USD, the upside of Amneal Pharmaceuticals Inc based on Relative Valuation is -47.8%.
The range of the Relative Valuation is 2.70 - 9.49 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 23.6x | 17.9x |
| Forward P/E multiples | 18.3x - 20.3x | 19.2x |
| Fair Price | 2.70 - 9.49 | 6.55 |
| Upside | -78.4% - -24.3% | -47.8% |
| Date | P/E |
| 2026-04-10 | 54.75 |
| 2026-04-09 | 55.89 |
| 2026-04-08 | 55.50 |
| 2026-04-07 | 53.79 |
| 2026-04-06 | 53.93 |
| 2026-04-02 | 54.49 |
| 2026-04-01 | 55.50 |
| 2026-03-31 | 54.27 |
| 2026-03-30 | 52.18 |
| 2026-03-27 | 51.74 |
| 2026-03-26 | 52.66 |
| 2026-03-25 | 53.53 |
| 2026-03-24 | 52.70 |
| 2026-03-23 | 52.05 |
| 2026-03-20 | 51.65 |
| 2026-03-19 | 53.88 |
| 2026-03-18 | 54.10 |
| 2026-03-17 | 54.27 |
| 2026-03-16 | 52.13 |
| 2026-03-13 | 51.65 |
| 2026-03-12 | 52.90 |
| 2026-03-11 | 55.50 |
| 2026-03-10 | 58.29 |
| 2026-03-09 | 57.85 |
| 2026-03-06 | 57.81 |
| 2026-03-05 | 57.90 |
| 2026-03-04 | 58.07 |
| 2026-03-03 | 58.12 |
| 2026-03-02 | 60.13 |
| 2026-02-27 | 60.30 |
| 2026-02-26 | 63.27 |
| 2026-02-25 | 63.66 |
| 2026-02-24 | 64.01 |
| 2026-02-23 | 62.96 |
| 2026-02-20 | 63.31 |
| 2026-02-19 | 63.75 |
| 2026-02-18 | 64.84 |
| 2026-02-17 | 66.33 |
| 2026-02-13 | 64.71 |
| 2026-02-12 | 63.88 |
| 2026-02-11 | 64.19 |
| 2026-02-10 | 64.45 |
| 2026-02-09 | 63.40 |
| 2026-02-06 | 63.40 |
| 2026-02-05 | 64.49 |
| 2026-02-04 | 63.01 |
| 2026-02-03 | 62.22 |
| 2026-02-02 | 61.96 |
| 2026-01-30 | 59.73 |
| 2026-01-29 | 61.61 |